Camille L. Bedrosian

Companies

• Amylyx PharmaceuticalsChief Medical Officer Nov 29, 2023 to now¹
• Rhythm (United states)Board member Dec 11, 2020 to now²
• Crinetics PharmaceuticalsBoard member Sep 3, 2020 to now³
• Ultragenyx Pharmaceutical Inc.EVP and Chief Medical Officer Jan 31, 2018 to Mar 3, 2023⁴
• ARIAD PharmaceuticalsVP, Chief Medical Officer Apr 18, 2007 to Apr 18, 2007⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Amylyx Pharmaceuticals AMLX278,064 shares⁶$7.5M at $27.07Sep 10, 2026
• UPUltragenyx Pharmaceutical Inc. RARE46,720 shares⁷$698.9K at $14.96Mar 1, 2023
• RURhythm (United states) RYTM7,000 shares⁸$617.8K at $88.25Jun 18, 2025
• Crinetics Pharmaceuticals0 shares⁹Sep 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 10, 2026Sold 2,081 shares at $33.09 of Amylyx Pharmaceuticals⁶
• Sep 10, 2026Sold 7,947 shares at $32.21 of Amylyx Pharmaceuticals⁶
• Sep 1, 2026Returned to company 5,925 shares at $85.00 of Crinetics Pharmaceuticals⁹
• Sep 1, 2026Returned to company 16,300 shares at $85.00 of Crinetics Pharmaceuticals⁹
• Aug 18, 2026Granted 22,807 shares of Amylyx Pharmaceuticals¹⁰
• Jun 18, 2026Granted 5,925 shares of Crinetics Pharmaceuticals¹¹
• Mar 5, 2026Granted 95,990 shares of Amylyx Pharmaceuticals¹²
• Mar 2, 2026Sold 6,461 shares at $14.58 of Amylyx Pharmaceuticals¹³
• Dec 1, 2025Sold 6,580 shares at $14.35 of Amylyx Pharmaceuticals¹⁴
• Sep 30, 2025Sold 12,039 shares at $14.58 of Amylyx Pharmaceuticals¹⁵
• Jun 18, 2025Exercised options 4,000 shares of Rhythm (United states)⁸
• Jun 11, 2025Granted 6,900 shares of Crinetics Pharmaceuticals¹⁶
• Mar 31, 2025Sold 12,425 shares at $3.47 of Amylyx Pharmaceuticals¹⁷
• Mar 6, 2025Granted 68,420 shares of Amylyx Pharmaceuticals¹⁸
• Dec 2, 2024Sold 5,421 shares at $5.54 of Amylyx Pharmaceuticals¹⁹
• Sep 30, 2024Sold 11,442 shares at $3.20 of Amylyx Pharmaceuticals²⁰
• Jun 21, 2024Exercised options 3,000 shares of Rhythm (United states)²¹
• Jun 7, 2024Granted 3,400 shares of Crinetics Pharmaceuticals²²
• Apr 16, 2024Granted 96,910 shares of Amylyx Pharmaceuticals²³
• Nov 27, 2023Granted 58,333 shares of Amylyx Pharmaceuticals²⁴
• Jun 16, 2023Granted 6,000 shares of Crinetics Pharmaceuticals²⁵
• Mar 1, 2023Sold 3,881 shares at $45.25 of Ultragenyx Pharmaceutical Inc.⁷
• Mar 1, 2023Granted 2,663 shares of Ultragenyx Pharmaceutical Inc.⁷
• Mar 1, 2022Granted 14,000 shares of Ultragenyx Pharmaceutical Inc.²⁶
• Mar 1, 2022Sold 2,821 shares at $66.62 of Ultragenyx Pharmaceutical Inc.²⁶